The CDKN2A/B genomic locus is associated with risk of human cancers and metabolic
disease. Although the locus contains several important protein-coding genes, studies …

The development and progression of melanoma have been attributed to independent or
combined genetic and epigenetic events. There has been remarkable progress in …

Gastric cancer is the third leading cause of cancer death with 5‐year survival rate of about
30–35%. Since early detection is associated with decreased mortality, identification of novel …

While our understanding of the molecular mechanisms underlying cancer has significantly
improved, most of our knowledge focuses on protein-coding genes that make up a fraction of …

Protein-coding genes account for only a small part of the human genome; in fact, the vast
majority of transcripts are comprised of non-coding RNAs (ncRNAs) including long ncRNAs …

Cancer constitutes a set of diseases with heterogeneous molecular pathologies. However,
there are a number of universal aberrations common to all cancers, one of these being the …

Background Mounting evidence indicates that long noncoding RNAs (lncRNAs) could play a
pivotal role in cancer biology. However, the overall biological role and clinical significance of …

Long non‐coding RNA s (lnc RNA s) are a group greater than 200 nucleotides in length. An
increasing number of studies has shown that lnc RNA s play important roles in diverse …

Gastric cancer remains a serious threat to public health with high incidence and mortality
worldwide. Accumulating evidence demonstrates that long non-coding RNAs (lncRNAs) …

Long non-coding RNAs (lncRNAs) are functional RNAs longer than 200 nucleotides. Recent
advances in the non-protein coding part of human genome analysis have discovered …